Oportun Financial (NASDAQ:OPRT) 주식

Oportun Financial

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

Oportun Financial Corporation - common stock

Oportun Financial Corp

Analysts' ratings for Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) over the last quarter vary from bullish to bearish, as provided by 20 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $59.65, a high estimate of $76.00, and a low estimate of $40.00. A decline of 18.95% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1746651623_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Celanese among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Bradley Thomas</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$46.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$48.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$75.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$50.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$59.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$72.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$56.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$46.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$110.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Celanese's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Celanese analyst ratings.</a>
<h2>Unveiling the Story Behind Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Celanese's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Celanese's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.8% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -0.88%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Celanese's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -0.41%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.09%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Celanese's debt-to-equity ratio stands notably higher than the industry average, reaching 2.52. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Breaking Down Celanese: 20 Analysts Share Their Views

UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $1.81 by 22.1 percent. This is a 12.18 percent increase over earnings of $1.97 per share from the same period last year. The company reported quarterly sales of $2.67 billion which missed the analyst consensus estimate of $3.26 billion by 18.22 percent. This is a 8.07 percent increase over sales of $2.47 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

UGI Q2 Adj. EPS $2.21 Beats $1.81 Estimate, Sales $2.67B Miss $3.26B Estimate

In the current session, the stock is trading at $80.84, after a 1.42% increase. Over the past month, Amphenol Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) stock increased by 22.15%, and in the past year, by 26.70%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1746651618_0.png" alt="Past Year Chart" />

<h3>Comparing Amphenol P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 43.71 in the Electronic Equipment, Instruments &amp; Components industry, Amphenol Inc. has a lower P/E ratio of 38.69. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1746651618_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into Amphenol Inc's Price Over Earnings

Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/25/05/b45265761/dutch-bros-inc-reports-first-quarter-2025-financial-results">figures from the quarter. </a>
The Details: Dutch Bros reported quarterly earnings of 14 cents per share, which beat the analyst consensus estimate of 11 cents. Quarterly revenue clocked in at $355.2 million, which beat the Street estimate of $344.67 million and is an increase over revenue of $275.1 million from the same period last year.
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a>
For the first quarter, Dutch Bros reported: 
<ul>
<li>Opened 30 new shops, 25 were company-operated, across 11 states.</li>
<li>Total revenues&nbsp;grew 29.1% to $355.2 million as compared to $275.1 million in the same period of 2024.</li>
<li>System same-shop sales and transactions increased 4.7% and 1.3%, respectively, relative to the same period in 2024.</li>
<li>Company-operated same-shop sales and transactions increased 6.9% and 3.7%, respectively, relative to the same period of 2024.</li>
<li>Company-operated shops revenues&nbsp;increased 31.6% to $326.4 million as compared to $248.1 million in the same period of 2024.</li>
<li>Company-operated shops gross profit&nbsp;was $71.5 million as compared to $54.3 million in the same period of 2024. </li>
<li>Company-operated shops gross margin, which includes 170 bps of pre-opening costs, was 21.9%, flat year-over-year.</li>
</ul>
&#8220;Our business continues to operate from a position of strength, and we are well-positioned to thrive in this dynamic environment. The enthusiasm for our brand, the loyalty of our customers, the passion of our team and a clear vision for our future give us great confidence,&#8221; Christine Barone, CEO of Dutch Bros, stated. 
Outlook:&nbsp;Dutch Bros affirmed its fiscal 2025 revenue outlook&nbsp;of between&nbsp;$1.55 billion and $1.57 billion, versus the $1.58 billion&nbsp;estimate.
BROS Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Dutch Bros stock was up 5.03% at $62.20 after-hours Wednesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/05/45239803/sarepta-therapeutics-stock-plummets-after-q1-results-heres-why?utm_source=articleShare">Sarepta Therapeutics Stock Plummets After Q1 Results: Here&#8217;s Why&nbsp;</a></li>
</ul>
Photo: Shutterstock

Restaurants

After-Hours Center

Movers

General

BROS

Dutch Bros Stock Climbs After Better-Than-Expected Q1 Report

RCM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCMT#NASDAQ">RCMT</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.55 by 14.55 percent. This is a 18.87 percent increase over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $84.47 million which beat the analyst consensus estimate of $77.80 million by 8.58 percent. This is a 17.42 percent increase over sales of $71.94 million the same period last year.

RCMT

RCM Technologies Q1 Adj. EPS $0.63 Beats $0.55 Estimate, Sales $84.47M Beat $77.80M Estimate

Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) has outperformed the market over the past 20 years by 1.34% on an annualized basis producing an average annual return of 9.51%. Currently, Starbucks has a market capitalization of $94.31 billion. 
Buying $100 In SBUX: If an investor had bought $100 of SBUX stock 20 years ago, it would be worth $612.67 today based on a price of $82.99 for SBUX at the time of writing.
<h3>Starbucks's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746651613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

SBUX

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Evolus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>) reported quarterly sales of $68.50 million which missed the analyst consensus estimate of $72.20 million by 5.13 percent. This is a 15.45 percent increase over sales of $59.33 million the same period last year.

EOLS

Evolus Q1 Sales $68.50M Miss $72.20M Estimate

WIIM

AOSL

Alpha and Omega Semiconductor shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance with its midpoint above estimates.

GDRX

GoodRx Holdings shares are trading higher after the company reported better-than-expected Q1 sales results.

SNCR

CORRECTION: Synchronoss Technologies Q1 Adj. EPS $(0.30) Misses $0.37 Estimate, Sales $42.21M Beat $42.15M Estimate

Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.22 by 250 percent. This is a 44.2 percent decrease over earnings of $1.38 per share from the same period last year. The company reported quarterly sales of $768.78 million which beat the analyst consensus estimate of $498.00 million by 54.37 percent. This is a 16.72 percent increase over sales of $658.64 million the same period last year.

Hamilton Insurance Group Q1 EPS $0.77 Beats $0.22 Estimate, Sales $768.78M Beat $498.00M Estimate

Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.29) by 24.14 percent. This is a 80.36 percent increase over losses of $(1.12) per share from the same period last year. The company reported quarterly sales of $8.72 million which beat the analyst consensus estimate of $2.13 million by 309.43 percent. This is a 114.91 percent increase over sales of $4.06 million the same period last year.

GBIO

Generation Bio Q1 EPS $(0.22) Beats $(0.29) Estimate, Sales $8.72M Beat $2.13M Estimate

Sunrun shares are trading higher after the company reported better-than-expected Q1 financial results.

Universal Technical Institute shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

Dutch Bros shares are trading higher after the company reported better-than-expected Q1 financial results.

Enhabit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 66.67 percent. This is a 42.86 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $259.90 million which missed the analyst consensus estimate of $266.05 million by 2.31 percent. This is a 0.95 percent decrease over sales of $262.40 million the same period last year.

EHAB

Enhabit Q1 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $259.90M Miss $266.05M Estimate

H&R Block shares are trading higher after the company reported better-than-expected Q3 financial results.

Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.47 by 6.38 percent. This is a 61.29 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $189.74 million which beat the analyst consensus estimate of $186.67 million by 1.64 percent. This is a 14.64 percent increase over sales of $165.51 million the same period last year.

QTWO

Q2 Holdings Q1 Adj. EPS $0.50 Beats $0.47 Estimate, Sales $189.74M Beat $186.67M Estimate

Claros Mortgage Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.09) by 177.78 percent. This is a 108.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $43.38 million which beat the analyst consensus estimate of $42.94 million by 1.01 percent. This is a 26.26 percent decrease over sales of $58.83 million the same period last year.

CMTG

Claros Mortgage Trust Q1 Adj. EPS $(0.25) Misses $(0.09) Estimate, Sales $43.38M Beat $42.94M Estimate

Applovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) reported financial results for the first quarter after the market close on Wednesday. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/b45266259/applovin-announces-first-quarter-2025-financial-results">from the report</a>.
Q1 Earnings: AppLovin reported first-quarter revenue of $1.48 billion, beating analyst&nbsp;<a href="http://benzinga.com/quote/app/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $1.38 billion, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported first-quarter earnings of $1.67 per share, beating analyst estimates of $1.45 per share.
Total revenue was up 40% year-over-year. Advertising revenue grew 71% year-over-year, while Apps revenue declined 14%. Cash flow from operations was $832 million in the quarter and free cash flow came in at $826 million. Applovin ended the quarter with approximately $551 million in cash and cash equivalents.
AppLovin also announced that it entered into a definitive agreement to sell its mobile gaming business to privately held Tripledot Studios for $400 million in cash, combined with a 20% ownership stake in Tripledot. The transaction is expected to close in the second quarter.
Outlook: AppLovin expects second-quarter advertising revenue in the range of $1.195 billion to $1.215 billion. The company anticipates second-quarter advertising adjusted EBITDA of $970 million to $990 million.
AppLovin executives will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
APP Price Action: <a href="http://benzinga.com/quote/app" target="_blank" rel="noreferrer noopener">Applovin shares</a> were trading lower before the <a href="https://www.benzinga.com/25/05/45264550/muddy-waters-doubles-down-on-applovin-in-new-short-report-ahead-of-q1-earnings">short report</a> from Muddy Waters Research. The stock was up 17.32% in Wednesday&#8217;s after-hours session, trading at $355.320 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45264550/muddy-waters-doubles-down-on-applovin-in-new-short-report-ahead-of-q1-earnings">Muddy Waters Doubles Down On AppLovin In New Short Report Ahead Of Q1 Earnings</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Piotr+Swat">Piotr Swat</a>/Shutterstock.

Short Sellers

Guidance

Tech

AppLovin Stock Shakes Off Short Seller Report, Shares Surge On Q1 Earnings Beat

Press Releases

Oportun to Report Fourth Quarter 2024 Financial Results on Wednesday, February 12, 2025

Oportun Reports Fourth Quarter and Full Year 2024 Financial Results

Oportun to Present at Sidoti March Virtual Investor Conference

FINDELL CAPITAL MANAGEMENT ISSUES OPEN LETTER TO BOARD AND SHAREHOLDERS OF OPORTUN (NASDAQ: OPRT) CALLING FOR LEADERSHIP CHANGE

Oportun Comments on Letter from Findell Capital

FINDELL CAPITAL MANAGEMENT RESPONDS TO OPORTUN (NASDAQ: OPRT) COMMENTS, ANNOUNCES NOMINATION OF SANDRA BELL AND WARREN WILCOX

Management

Oportun Comments on Director Nominations

Financing

Oportun Closes $187.5 Million Committed Warehouse Facility

Oportun to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

FINDELL CAPITAL PARTNERS DELIVERS LETTER TO OPORTUN STOCKHOLDERS AHEAD OF 2025 ANNUAL MEETING

OPRT

Senmiao Technology Limited - Common Stock

Senmiao Tech

Consumer Portfolio Services, Inc. - Common Stock

Consumer Pf Servs

DeFi Development

Green Dot Corporation Class A Common Stock, $0.001 par value

Green Dot

Jiayin Group Inc. - American Depositary Shares

Jiayin Gr

Katapult Holdings

Metalpha Technology Holding Limited - Ordinary Shares

Metalpha Technology

Medallion Financial

Nerdwallet

OppFi

PRA Group

Pintec Technology Holdings Limited - American Depositary Shares

Pintec Technology Hldgs

Qudian Inc. American Depositary Shares, each representing one Class A Ordinary Share

Qudian

Regional Management

LendingTree

World Acceptance Corporation - Common Stock

World Acceptance

X Financial American Depositary Shares, each representing six Class A Ordinary Shares

X Financial

Yiren Digital Ltd. American Depositary Shares, each representing two ordinary shares

Comments

Oportun Financial

뉴스

파트너 / 기고자

벤징가 글로벌